Head-To-Head Contrast: Heart Test Laboratories (NASDAQ:HSCS) and Jin Medical International (NASDAQ:ZJYL)

Jin Medical International (NASDAQ:ZJYL) and Heart Test Laboratories (NASDAQ:HSCS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability.

Earnings and Valuation

This table compares Jin Medical International and Heart Test Laboratories”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$20.13 million	8.09	$2.88 million	N/A	N/A
Heart Test Laboratories	$14,700.00	254.00	-$6.61 million	($7.91)	-0.48

Jin Medical International has higher revenue and earnings than Heart Test Laboratories.

Profitability

This table compares Jin Medical International and Heart Test Laboratories’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
Heart Test Laboratories	N/A	-144.12%	-94.48%

Insider & Institutional Ownership

17.2% of Heart Test Laboratories shares are held by institutional investors. 1.8% of Heart Test Laboratories shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Volatility & Risk

Jin Medical International has a beta of 13.55, meaning that its share price is 1,255% more volatile than the S&P 500. Comparatively, Heart Test Laboratories has a beta of 3.23, meaning that its share price is 223% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Jin Medical International and Heart Test Laboratories, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	0	0	0	0	0.00
Heart Test Laboratories	0	0	2	0	3.00

Heart Test Laboratories has a consensus price target of $13.50, indicating a potential upside of 254.33%. Given Heart Test Laboratories’ stronger consensus rating and higher probable upside, analysts clearly believe Heart Test Laboratories is more favorable than Jin Medical International.

Summary

Heart Test Laboratories beats Jin Medical International on 6 of the 11 factors compared between the two stocks.

About Jin Medical International

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

About Heart Test Laboratories

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.